Genentech: Home

News & Features

		Genentech at ASCO 2008 At the annual ASCO meeting in Chicago, IL, May 30 - June 3, Genentech medicines and investigational agents will be featured in nearly 400 abstracts across 15 tumor types. View the press releases below for an overview of some of the key data to be presented at this year's meeting. Avastin ASCO Press Release BioOncology Pipeline ASCO Press Release



		Accelerated Approval for Avastin in Breast Cancer On February 22, 2008, the FDA granted accelerated approval for Avastin in combination with paclitaxel chemotherapy for the first-line treatment of advanced HER2-negative breast cancer.


Investor Webcasts >>
Event:	Deutsche Bank 33rd Annual Healthcare Conference
Date:	May 6, 2008
Time:	11:30 a.m. ET
	Archive



Event:	2008 Bank of America Healthcare Conference
Date:	May 14, 2008
Time:	11:20 a.m. PT
	Archive



Event:	Baird's 2008 Growth Stock Conference
Date:	May 14, 2008
Time:	8:20 a.m. CT
	Archive

Genentech is committed to making sure price is not a barrier to access for patients.

FORTUNE magazine has named Genentech to its "100 Best Companies to Work For" and "America's Most Admired" lists.

Genentech's postdoctoral program offers the chance to do cutting-edge research in an inspiring environment.